In Brief: DXM, NPLEx, AHPA, Merck, Novel Ingredients
This article was originally published in The Tan Sheet
Executive Summary
Nexium 24HR label posted; Washington state bans DXM sales to minors; South Dakota joins NPLEx; AHPA issues protein calculation guidance; Merck names new CFO; Private equity firm invests in Novel Ingredient Services; and more In Brief.